The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

Green, A. Richard, Mechan, Annis O., Elliott, J. Martin, O’Shea, Esther, Colado, M. Isabel·2003·Pharmacological Reviews
DOI 10.1124/pr.55.3.3

Cited by (1,000)

Items 601–700 of 1,000

  1. Effects of MDMA (ecstasy) on apoptosis and heat shock protein (HSP70) expression in adult rat testis
    Fahimeh Mobaraki, Masoumeh Seghatoleslam, Alireza Fazel, Alireza Ebrahimzadeh‐Bideskan · 2017 · Toxicology Mechanisms and Methods
  2. Experience-dependent changes in temperature and behavioral activity induced by MDMA
    Maria Elena Reveron, Esther Y. Maier, Christine L. Duvauchelle · 2006 · Physiology & Behavior
  3. Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice
    María Juliana Orejarena, Fernando Berrendero, Rafael J. Maldonado, Patricia Robledo · 2009 · Psychopharmacology
  4. Persistent cerebrovascular effects of MDMA and acute responses to the drug
    Linda Ferrington, Eszter Kirilly, Douglas E. McBean, Henry J. Olverman, György Bagdy, Paul A. T. Kelly · 2006 · European Journal of Neuroscience
  5. Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA (‘Ecstasy’): An 18F-Dopa PET Study
    Yen Tai, Rosa Hoshi, Catherine M. Brignell, Lisa Cohen, David James Brooks, H. Valerie Curran, Paola P. Piccini · 2010 · Neuropsychopharmacology
  6. The Effect of MDMA-Induced Anxiety on Neuronal Apoptosis in Adult Male Rats' Hippocampus
    S. Karimi, Mehrdad Jahanshahi, Mohammad Jafar Golalipour · 2014 · Folia Biologica
  7. Increased responsiveness to MDMA in adult rats treated neonatally with MDMA
    Brian J. Piper, Jerrold S. Meyer · 2005 · Neurotoxicology and Teratology
  8. MDMA treatment paired with a trauma-cue promotes adaptive stress responses in a translational model of PTSD in rats
    Shira Arluk, Michael Alex Matar, Lior Carmi, Oded Arbel, Joseph Zohar, Doron Todder, Hagit Cohen · 2022 · Translational Psychiatry
  9. Oxygen plasma-treated graphite sheet electrodes: A sensitive and disposable sensor for methamphetamines
    Jian F.S. Pereira, Larissa Magalhães de Almeida Melo, Luciano Chaves Arantes, Pedro H. S. Borges, Lucas V. de Faria, Kelly Francisco da Cunha, Karla A.O. Souza, William Oliveira Soté, José Luiz Costa, Edson Nossol et al. · 2023 · Electrochimica Acta
  10. PRECLINICAL STUDY: FULL ARTICLE: Tolerance to 3,4‐methylenedioxymethamphetamine is associated with impaired serotonin release
    Karen L. Jones, Katharine Alexandra Brennan, Joyce Colussi‐Mas, Susan Schenk · 2010 · Addiction Biology
  11. The heat is on: Molecular mechanisms of drug-induced hyperthermia
    Christine K. Dao, Sara M. Nowinski, Edward Mills · 2014 · Temperature
  12. Preexposure to MDMA (“Ecstasy”) delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats
    Kirsten C. Morley, Jennifer Louise Cornish, Kong M. Li, Iain S. McGregor · 2004 · Pharmacology Biochemistry and Behavior
  13. Active and passive MDMA (‘ecstasy’) intake induces differential transcriptional changes in the mouse brain
    Noèlia Fernàndez-castillo A, María Juliana Orejarena, Marta Ribasés, Enrique Blanco, Miguel Casas, Patricia Robledo, Rafael J. Maldonado, Bru Cormand · 2011 · Genes Brain & Behavior
  14. Serotonin antagonists fail to alter MDMA self-administration in rats
    Susan Schenk, Jason Foote, Dane Aronsen, Natasha Bukholt, Quenten Highgate, Ross van de Wetering, Jeremy Webster · 2016 · Pharmacology Biochemistry and Behavior
  15. Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence
    Cristina Cadoni, Augusta Pisanu, Nicola Simola, Lucia Frau, Pier Francesca Porceddu, Silvia Corongiu, Christian Dessì, Annesha Sil, Antonio Plumitallo, Jadwiga Wardas et al. · 2017 · Neuropharmacology
  16. 5-Iodo-2-aminoindan (5-IAI): Chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects
    Maurizio Coppola, Raffaella Mondola · 2013 · Toxicology Letters
  17. Ecstasy (MDMA) and its effects on kidneys and their treatment: a review.
    Feyza Bora, Fatih Yılmaz, Taner Bora · 2016 · PubMed Central
  18. Neurotoxicity of MDMA (ecstasy): beyond metabolism
    Jon E. Sprague, David E. Nichols · 2004 · Trends in Pharmacological Sciences
  19. Effects of stress and MDMA on hippocampal gene expression
    Weber, Georg F., Johnson, Bethann N., Yamamoto, Bryan K., Gudelsky, Gary A. · 2014 · BioMed Research International
  20. Drinking to death: Hyponatraemia induced by synthetic phenethylamines
    Ana Carolina Faria, Helena Carmo, Félix Dias Carvalho, João Pedro Silva, Maria de Lourdes Bastos, Diana Dias da Silva · 2020 · Drug and Alcohol Dependence
  21. MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy
    Mesud Sarmanlu, Kim P. C. Kuypers, Patrick Vizeli, Timo Lehmann Kvamme · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  22. The effects of concurrent administration of (±)3,4-Methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat
    Anna Jean Diller, Angelica Rocha, Aaron L. Cardon, Rodrigo Valles, Paul Jeff Wellman, Jack R. Nation · 2007 · Pharmacology Biochemistry and Behavior
  23. Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats
    Mark Galizio, P McKinney, Daniel T. Cerutti, Raymond C. Pitts · 2009 · Pharmacology Biochemistry and Behavior
  24. Mixtures of 3,4‐methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non‐cytotoxic concentrations
    Diana Dias da Silva, Elisabete A. Silva, Félix Dias Carvalho, Helena Carmo · 2013 · Journal of Applied Toxicology
  25. Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational ‘ecstasy’
    Andrew C. Parrott · 2016 · Behavioural Pharmacology
  26. MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014–2017
    Roberta Noseda, Yasmin Schmid, Irene Scholz, Evangelia Liakoni, Matthias E. Liechti, Paul Ivor Dargan, David Michael Wood, Alison M. Dines, Chris Yates, Fridtjof Heyerdahl et al. · 2020 · Clinical Toxicology
  27. Binge Ethanol and MDMA Combination Exacerbates Toxic Cardiac Effects by Inducing Cellular Stress
    Javier Navarro‐Zaragoza, Clara Ros‐Simó, M. Victoria Milanés, Olga Valverde, M. Luisa Laorden · 2015 · PLoS ONE
  28. 4-methylthioamphetamine-induced hyperthermia in mice: influence of serotonergic and catecholaminergic pathways
    Helena Carmo, Fernando Remião, Félix Dias Carvalho, Eduarda G. R. Fernandes, Douwe de Boer, Lesseps A. dos Reys, Maria de Lourdes Bastos · 2003 · Toxicology and Applied Pharmacology
  29. Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in dark agouti rat
    Csaba Ádori, Rómeó D. Andó, Mária Szekeres, Lise Gutknecht, Gábor Géza Kovács, László Hunyady, Klaus‐Peter Lesch, György Bagdy · 2011 · The Journal of Comparative Neurology
  30. Repeated adolescent MDMA (“Ecstasy”) exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist
    Dominik K. Biezonski, Andrea B. Courtemanche, Sang B. Hong, Brian J. Piper, Jerrold S. Meyer · 2008 · Brain Research
  31. S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA
    Anna M. S. Kindlundh-Högberg, Xiaoqun Zhang, Per Svenningsson · 2008 · The International Journal of Neuropsychopharmacology
  32. Reduced efficacy of fluoxetine following MDMA (“Ecstasy”)-induced serotonin loss in rats
    Sarah Durkin, Alison Prendergast, Andrew Harkin · 2008 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  33. The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes
    Emily Joy Jaehne, Abdallah Salem, Rodney James Irvine · 2008 · Psychopharmacology
  34. Enhanced hippocampal long-term potentiation following repeated MDMA treatment in Dark-Agouti rats.
    Raffaella Morini, B. Mlinar, G. Baccini, R. Corradetti · 2011 · European Neuropsychopharmacology
  35. Severe Ecstasy poisoning in a toddler
    Michael Duffy, M. Swart · 2006 · Anaesthesia
  36. Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): Identification of extracellular signal-regulated kinase-controlled genes
    J. Salzmann, Corinne Canestrelli, Florence Noble, Cynthia Marie-claire A · 2005 · Neuroscience
  37. Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs
    Jon C. Cole, Harry R. Sumnall, G. W. Smith, Amin Rostami‐Hodjegan · 2005 · Journal of Psychopharmacology
  38. Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: A study comparing current and ex-ecstasy users with polydrug and drug-naive controls.
    Rosa Hoshi, Lisa Janet Cohen, Lucy Lemanski, Paola P. Piccini, Alyson J. Bond, H. Valerie Curran · 2007 · Experimental and Clinical Psychopharmacology
  39. Ethanol–ecstasy (MDMA) interactions in rats: Preserved attenuation of hyperthermia and potentiation of hyperactivity by ethanol despite prior ethanol treatment
    Sami Ben Hamida, Sonia Bach, Erin Plute, Byron C. Jones, Christian R. Kelche, Jean‐Christophe Cassel · 2006 · Pharmacology Biochemistry and Behavior
  40. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study
    Jörg Daumann, Bianca Till, Thomas Fischermann, Markus Rezk, Euphrosyne Gouzoulis‐Mayfrank · 2006 · Journal of Psychopharmacology
  41. Differential Substitution for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate in Rats
    Tomohisa Mori, Naoki Uzawa, Haruyo Kazawa, Hirohiko Watanabe, Ayano Mochizuki, Masahiro Shibasaki, Kazumi Yoshizawa, Kimio Higashiyama, Tsutomu Suzuki · 2014 · Journal of Pharmacology and Experimental Therapeutics
  42. White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels
    Josua Zimmermann, Nicole Friedli, Francesco Bavato, Philipp Stämpfli, Rebecca C. Coray, Markus R. Baumgartner, Denis Grandgirard, Stephen L. Leib, Antje Opitz, Erich Seifritz et al. · 2022 · NeuroImage Clinical
  43. Dopamine transporter down‐regulation following repeated cocaine: implications for 3,4‐methylenedioxymethamphetamine‐induced acute effects and long‐term neurotoxicity in mice
    Inés Peraile, Elisa Torres, Andrea Mayado, María Izco, Alejandro López‐Jiménez, José Antonio López‐Moreno, MI Colado, Esther O’Shea · 2009 · British Journal of Pharmacology
  44. N,N‐dimethyl‐thioamphetamine and methyl‐thioamphetamine, two non‐neurotoxic substrates of 5‐HT transporters, have scantin vitroefficacy for the induction of transporter‐mediated 5‐HT release and currents
    Marco Gobbi, Marcella Funicello, Klaus Gerstbrein, Marion Holy, Pablo R. Moya, Ramón Sotomayor‐Zárate, Marı́a Inés Forray, Katia Gysling, Silvio Paluzzi, Giambattista Bonanno et al. · 2008 · Journal of Neurochemistry
  45. A Study on the Mechanism by Which MDMA Protects Against Dopaminergic Dysfunction After Minimal Traumatic Brain Injury (mTBI) in Mice
    Shahaf Edut, Vardit Rubovitch, Moshe Rehavi, Shaul Schreiber, Chaim G. Pick · 2014 · Journal of Molecular Neuroscience
  46. Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans
    Andrea Eva Steuer, Corina Schmidhauser, Eva H. Tingelhoff, Yasmin Schmid, Anna Rickli, Thomas Kræmer, Matthias E. Liechti · 2016 · PLoS ONE
  47. An analysis of spontaneous behavior following acute MDMA treatment in male and female rats.
    Tomáš Páleníček, Zdenek Hlinak, Vĕra Bubeníková‐Valešová, Martin Votava, Jiřı́ Horáček · 2007 · PubMed
  48. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain
    Lucia Frau, Nicola Simola, Pier Francesca Porceddu, Micaela Morelli · 2016 · NeuroToxicology
  49. A long-term ecstasy-related change in visual perception
    John Brown, Mark Edwards, Elinor McKone, Jeff Ward · 2007 · Psychopharmacology
  50. THE SHAMAN AND THE RAVE PARTY: SOCIAL PHARMACOLOGY OF ECSTASY
    Paolo Nencini · 2002 · Substance Use & Misuse
  51. Priapism, Ecstasy, and Marijuana: Is There a Connection?
    Quan T. Tran, Robyn Anne Wallace, Esther Sim · 2008 · Advances in Urology
  52. MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study
    V. Raj, HC Liang, Neil D. Woodward, Amy L. Bauernfeind, Junghee Lee, MS Dietrich, Sohee Park, Ronald L. Cowan · 2009 · Journal of Psychopharmacology
  53. A validated gas chromatographic–electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain
    Karl B. Scheidweiler, Allan J. Barnes, Marilyn Ann Huestis · 2008 · Journal of Chromatography B
  54. On the Effects of Psychostimulants, Antidepressants, and the Antiparkinsonian Drug Levodopa on Dopamine Neurons
    Raffaella Geracitano, Mauro Federici, Giorgio Bernardi, Nicola Biagio Mercuri · 2006 · Annals of the New York Academy of Sciences
  55. The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene
    Thelma Schilt, Maarten W.J. Koeter, Maartje M. L. de Win, Janneke Zinkstok, Thérèse van Amelsvoort, Ben A. Schmand, Wim van den Brink · 2008 · European Neuropsychopharmacology
  56. Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation
    Emily Joy Jaehne, A SALEM, R Julian Irvine · 2005 · Pharmacology Biochemistry and Behavior
  57. Decreased pain tolerance and mood in recreational users of MDMA
    Margaret Claire O'Regan, Angela Clow · 2004 · Psychopharmacology
  58. Effects of group exposure on single injection-induced behavioral sensitization to drugs of abuse in mice
    Roberta Procópio‐Souza, Daniela Fukue Fukushiro, Thaís Fernanda Trombin, Raphael Wuo‐Silva, Lineane Helena Fernandes Zanlorenci, Alexandre J.O. Lima, Luciana Takahashi Carvalho Ribeiro, Jussara M. R. M. Corrêa, E.A.V. Marinho, Sonia Regina Kameda et al. · 2011 · Drug and Alcohol Dependence
  59. A role for adenosine A1 receptor blockade in the ability of caffeine to promote MDMA “Ecstasy”-induced striatal dopamine release
    Natacha Vanattou‐Saïfoudine, Anna Gossen, Andrew Harkin · 2010 · European Journal of Pharmacology
  60. PRECLINICAL STUDY: Modulation of MDMA‐induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice
    Emilie Belkaï, Jean‐Michel Scherrmann, Florence Noble, Cynthia Marie-claire A · 2009 · Addiction Biology
  61. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits
    Luke A. Downey, Helen Sands, Lewis Jones, Angela Clow, Phil D. Evans, Tobias Stalder A, Andrew C. Parrott · 2015 · Human Psychopharmacology Clinical and Experimental
  62. Targeting the GABAB Receptor for the Treatment of Substance Use Disorder
    Małgorzata Frankowska, Edmund Przegaliński, Małgorzata Filip · 2016 · Springer eBooks
  63. Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’)
    M.A. Aguilar, María Pilar García-Pardo, Andrew C. Parrott · 2019 · Brain Research
  64. Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females
    Jessica Duncan Cance, Olivia Silber Ashley, Michael A. Penne · 2005 · Journal of Adolescent Health
  65. POTENTIATION OF 3,4‐METHYLENEDIOXYMETHAMPHETAMINE‐INDUCED 5‐HT RELEASE IN THE RAT SUBSTANTIA NIGRA BY CLORGYLINE, A MONOAMINE OXIDASE A INHIBITOR
    Ryan Hewton, Abdallah Salem, Rodney James Irvine · 2007 · Clinical and Experimental Pharmacology and Physiology
  66. Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio
    Rüssel S. Falck, Jichuan Wang, Robert Gideon Carlson, Harvey Alan Siegal · 2005 · Addictive Behaviors
  67. Neurotoxic Emergencies
    J. Dave Barry, Brandon K. Wills · 2011 · Neurologic Clinics
  68. An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague–Dawley rats
    J Panos, Lisa E. Baker · 2010 · Psychopharmacology
  69. Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain
    Thomas J.R. Beveridge, Annis O. Mechan, Marie Sprakes, Qi Pei, Tyra Zetterström, A. Richard Green, J. Martin Elliott · 2004 · Psychopharmacology
  70. Neurological and Psychopathological Sequelae Associated With a Lifetime Intake of 40,000 Ecstasy Tablets
    Christos Kouimtsidis, Fabrizio Schifano, Lisa Ford, Justin Robinson, Colm Magee · 2005 · Psychosomatics
  71. Persistent sensitisation to the locomotor activating effects of MDMA following MDMA self-administration in rats
    Susan Schenk, Sarah Bradbury · 2015 · Pharmacology Biochemistry and Behavior
  72. Microextraction Techniques for Sample Preparation of Amphetamines in Urine: A Comprehensive Review
    Nasim Nourani, Arezou Taghvimi, Ahad Bavili Tabrizi, Yousef Javadzadeh, Siavoush Dastmalchi · 2022 · Critical Reviews in Analytical Chemistry
  73. Substances from unregulated drug markets – A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland)
    Raphael Magnolini, Martina Schneider, Dominique Schori, Daniel Trachsel, Philip Bruggmann · 2023 · International Journal of Drug Policy
  74. Developmental outcomes of 3,4‐methylenedioxymethamphetamine (ecstasy)‐exposed infants in the UK
    Lynn T. Singer, Derek G. Moore, Meeyoung Oh Min, Julia E. Goodwin, John J. Turner, Sarah E. Fulton, Andrew C. Parrott · 2015 · Human Psychopharmacology Clinical and Experimental
  75. Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decision making
    Sybille Schulz, Thorsten Becker, Ulrich Nagel, Andreas von Ameln-Mayerhofer, Michael Koch · 2013 · Pharmacology Biochemistry and Behavior
  76. Intermittent prenatal MDMA exposure alters physiological but not mood related parameters in adult rat offspring
    Csaba Ádori, Dóra Zelena, Júlia Tímár, Zsuzsa Gyarmati, Ágnes Domokos, Melinda Sobor, Zsuzsanna Fürst, Gábor B. Makara, György Bagdy · 2009 · Behavioural Brain Research
  77. Fluoxetine treatment of prepubertal male rats uniformly diminishes sex hormone levels and, in a subpopulation of animals, negatively affects sperm quality
    Marı́a Elena Ayala, Ayari Gonzáles, Rodrigo M. Olivarez, Andrés Aragón Martínez · 2018 · Reproduction Fertility and Development
  78. Greater sexual risk‐taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study
    Aimee L. May, Andrew C. Parrott · 2015 · Human Psychopharmacology Clinical and Experimental
  79. In vivoanalysis of serotonin clearance in rat hippocampus reveals that repeated administration of p‐methoxyamphetamine (PMA), but not 3,4‐methylenedioxymethamphetamine (MDMA), leads to long‐lasting deficits in serotonin transporter function
    Paul D. Callaghan, William Anthony Owens, Martin A. Javors, Teresa A. Sanchez, David John Jones, Rodney James Irvine, Lynette C. Daws · 2006 · Journal of Neurochemistry
  80. N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats
    Richard A. Glennon, Richard Young, Maƚgorzata Dukat, Jean Chang‐Fong, Mohamed Ayman El‐Zahabi · 2007 · Pharmacology Biochemistry and Behavior
  81. Synaptotagmin I and IV are differentially regulated in the brain by the recreational drug 3,4-methylenedioxymethamphetamine (MDMA)
    Weiping Peng, Premkumar Arumugam, Rainald Mößner, Mitsunori Fukuda, Klaus‐Peter Lesch, Rabi Simantov · 2002 · Molecular Brain Research
  82. MDMA Induces EPSP–Spike Potentiation in Rat Ventral Hippocampus In Vitro Via Serotonin and Noradrenaline Release and Coactivation of 5-HT4 and β1 Receptors
    B. Mlinar, Simona Mascalchi, Raffaella Morini, F. Giachi, R. Corradetti · 2008 · Neuropsychopharmacology
  83. Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: A potential link to the long-term recovery of serotonergic axons
    Csaba Ádori, Rómeó D. Andó, Linda Ferrington, Mária Szekeres, Szilvia Vas, Paul A.T. Kelly, László Hunyady, György Bagdy · 2010 · Neuroscience Letters
  84. Development and validation of an LC‐MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy‐methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma
    Andrea Eva Steuer, Corina Schmidhauser, Matthias E. Liechti, Thomas Kræmer · 2014 · Drug Testing and Analysis
  85. Differentiation of MDMA or 5-MeO-DIPT induced cognitive deficits in rat following adolescent exposure.
    David M. Compton, Melissa C. Selinger, Eric Westman, Peter Otero · 2011 · Psychology & Neuroscience
  86. 3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture
    Jack W. Lipton, Emeline G. Tolod, Valerie B. Thompson, Lin Pei, Katrina L. Paumier, Brian T. Terpstra, Kaari A. Lynch, Timothy J. Collier, Caryl E. Sortwell · 2008 · Neuropharmacology
  87. Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse
    Carlo Marchesi, Matteo Tonna, Carlo Maggini · 2008 · The World Journal of Biological Psychiatry
  88. Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre‐treatment against 3,4‐methylenedioxymethamphetamine toxicity in rat brain
    Isabel Escobedo, Inés Peraile, Laura Orío, María Isabel Colado, Esther O’Shea · 2007 · Journal of Neurochemistry
  89. MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission
    Rabi Simantov, Weiping Peng · 2004 · FEBS Letters
  90. Distribution of Methamphetamine and Its Metabolite Amphetamine in Acute and Subacute Ethanol-Methamphetamine Combination Abuse Model Rats
    Man Liang, Y. Liu, N. Zheng, S. Ananda, Li Liu · 2012 · Journal of Analytical Toxicology
  91. Central Nervous System Alterations in Drug Abuse
    Andreas Büttner, Serge Weis · 2004 · Forensic pathology reviews
  92. Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs)
    A. Richard Green, David Nutt · 2014 · Journal of Psychopharmacology
  93. 3,4-Methylenedioxymethamphetamine as a Psychiatric Treatment
    Gillinder Bedi · 2018 · JAMA Psychiatry
  94. Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats
    Dominik K. Biezonski, Brian J. Piper, Nina M. Shinday, Peter J. Kim, Syed F. Ali, Jerrold S. Meyer · 2012 · European Journal of Pharmacology
  95. Antidepressant‐like effects of ecstasy in subjects with a predisposition to depression
    Irina Majumder, Jason M. White, Rodney James Irvine · 2012 · Addictive Behaviors
  96. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders
    Inés Peraile, Noelia Granado, Elisa Torres, María Dolores Gutiérrez‐López, Rosario Moratalla, María Isabel Colado, Esther O’Shea · 2013 · Psychopharmacology
  97. 3,4-Methylenedioxymethamphetamine Induces Gene Expression Changes in Rats Related to Serotonergic and Dopaminergic Systems, But Not to Neurotoxicity
    Elisabet Cuyàs, Patricia Robledo, Nieves Pizarro, Magı́ Farré, Elena Puerta, Norberto Aguirre, Rafael de la Torre · 2013 · Neurotoxicity Research
  98. The acute effects of MDMA and ethanol administration on electrophysiological correlates of performance monitoring in healthy volunteers
    Desirée B. Spronk, Glenn Dumont, Robbert‐Jan Verkes, Ellen R. A. de Bruijn · 2014 · Psychopharmacology
  99. Single oral doses of (±) 3,4-methylenedioxymethamphetamine (‘Ecstasy’) produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations
    Melanie Mueller, Jie Yuan, Una D. McCann, George Hatzidimitriou, George A. Ricaurte · 2012 · The International Journal of Neuropsychopharmacology
  100. A Gas Chromatography–Mass Spectrometry Method for Toxicological Analysis of MDA, MDEA and MDMA in Vitreous Humor Samples from Victims of Car Accidents
    Aline Akemi Ishikawa, Dayanne Mozaner Bordin, Eduardo Geraldo de Campos, Lucas Blanes, Philip Doble, Bruno Spinosa De Martinis · 2018 · Journal of Analytical Toxicology